Patients with fever of unknown origin (FUO): Diagnosis by nuclear medicine imaging;Nuklearmedizinische diagnostik bei patienten mit fieber unklarer genese (FUO)

NuklearMedizin

Volumn 40, Issue 3, 2001, Pages 59-70

  Meller, J ^a   Becker, W ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Fever of unknown origin; FUO; PET; Scintigraphy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67; TRACER;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL LABELING; CHRONIC INFLAMMATION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; GRANULOMATOUS INFLAMMATION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; LEUKOCYTE; NEOPLASM; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PUS; PYREXIA IDIOPATHICA; REVIEW; SCINTILLATION CAMERA; VASCULAR DISEASE;

EID: 0034915511     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623872     Document Type: Review

References (108)

1. Fluorine-18-fluorodeoxyglucose uptake in rheumatoid arthritis-associated lung disease in a patient with thyroid cancer
2. Nonopsonic phagocytosis of Pseudomonas aeruginosa requires facilitated transport of D-glucose by macrophages
3. Immunoscintigraphy of infectious lesions
4. Entzündungsdiagnostik mit autologen leukozyten und murinen monoklonalen antikörpern
5. Nuklearmedizinische methoden
6. Entzündungen
7. The contribution of nuclear medicine to the patient with infection
8. Use of immunoscintigraphy in the diagnosis of fever of unknown origin
9. The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
10. Differentialindikation für verschiedene radioaktive arzneimittel bei unterschiedlichen entzündlichen erkrankungen
11. Fever of unknown origin in the elderly. A sequential approach to diagnosis
12. Fever of unknown origin in HIV-infected patients: A critical analysis of a retrospective series of 57 cases
13. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on Carcinoembryonic antigen (CEA)
14. Gallium scanning in children with fever of unknown origin
15. Overexpression of glut-1 glucose transporter in human breast cancer
16. Energy metabolism of human neutrophils during phagocytosis
17. Ultrasonography and indium 111 white blood cell scanning for the detection of intraabdominal abscesses
18. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin
19. Inhibition of Ga-67 uptake in melanoma by a antihuman transferrin receptor monoclonal antibody
20. Indium-111-labeled leukocyte scan in detection of synthetic vascular graft infection: The effect of antibiotic treatment
21. Dissociation of indium from indium-111-labeled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci
22. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine
23. Fever of unknown origin
24. Effect of antibiotic therapy on the sensitivity of indium-111-labeled leukocyte scans
25. The role of Indium-labeled leukocyte imaging in pyrexia of unknown origin
26. Technetium-99m labelled policlonal human immunoglobulin scintigraphy predicts rheumatoid arthritis in patients with arthralgia
27. Technetium-99m labelled policlonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis
28. Fever of unknown origin (FUO): Report on 53 patients in a Durch University hospital
29. Fever of unknown origin (FUO). II. Diagnostic procedures in a prospective multicenter study of 167 patients
30. Utility of indium-111-labeled polyclonal immunoglobulin G scintigraphy in fever of unknown origin
31. Evolution of the clinical manifestations of infection during the course of febrile neutropenia in patients with malignancy
32. Zytokine in der pathogenese des fiebers
33. Leitsymptom fieber
34. In vitro culture of murine peritoneal and alveolar macrophages modulates phagocytosis of Pseudomonas aeruginosa and glucose transport
35. Analysis of glucose metabolism in patients with esophageal cancer by FDG-PET: Estimation of hexokinase activity in the tumor and prediction of prediction of prognosis: Clinical PET in Oncology
36. Augmentations of glucose uptake and glucose transporter-1 in macrophages following thermal injury and sepsis in mice
37. 99mT1 labeled antigranulocyte monoclonal antibody Fab fragments (LeukoScan®) for diagnostic imaging of bone and soft tissue infections
38. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin
39. 99mTc-MDP for estimating the severity of vertebral osteomyelitis
40. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis
41. Experimental studies of [18F]-2-fluoro-2′-deoxy-D-glucose (FDG) in infection and in reactive lymph nodes
42. Gallium-67 citrate scans in febrile patients
43. Indium 111 autologous granulocytes in the diagnosis of abscess and in the assessment of inflammatory bowel disease
44. Ga-67 scanning in pyrexia of unknown origin
45. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors
46. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography
47. Fokussuche bei neutropenischem fieber
48. Gallium: Mechanisms
49. The association of Ga-67 and lactoferrin
50. FDG-PET in infectious lesions: Detection and assessment of lesion activity
51. 67Ga tumor scanning and its mechanisms studied in rabbits
52. 111In-oxine labelled leukocyte scintigraphy in the detection and localization of active inflammation and sepsis
53. Diagnosis of abdominal abscesses with computed tomography, ultrasound, and in-111 leucocyte scans
54. Clinical value of gallium-67 scintigraphy in the investigation of fever or inflammation of unknown origin in the ultrasound and computed tomography era
55. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature
56. Clinical value of gallium-67 scintigraphy in evaluation of fever of unknown origin
57. Evaluation of pulmonary lesions with positron emission tomography
58. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulocytes studied by microautoradiography
59. Fever of undetermined origin: Diagnosis and follow-up of 105 cases, 1970-1980
60. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis
61. Einsatz der F-18-FDG PET bei patienten mit unklarem fieber
62. Indium labelled leucocyte scanning in pyrexia of unknown origin
63. Clinical implications of radiolabeled blood elements in inflammatory bowel disease
64. Evaluation of 111-In Leukocyte Whole Body scanning
65. A prospective study of computed tomography, ultrasound, and gallium imaging in patients with fever
66. Clinical value of immunoscintigraphy in patients with fever of unknown origin
67. Fever of unknown origin-prospective comparison of 18 FDG-imaging with a double head coincidence camera (DHCC) and Ga-67 citrate SPECT
68. 18-FDG uptake bei einer patientin mit fibröser Thyreoiditis (Riedel Thyreoiditis)
69. 111In-labelled human IgG scintigraphy
70. Immunoscintigraphy using technetium-99m-labelled anti-NCA-95 antigranulocyte antibodies as an adjunct to echocardiography in subacute infective endocarditis
71. PET scanning and the human immunodeficiency virus-positive patient
72. The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography
73. Diagnosing infection in febrile granulocytopenic patients with indium-111 labeled human immunoglobulin
74. Radionuclide imaging of nonosseous infection
75. Focal pulmonary abnormalities: Evaluation with F-18 Fluorodeoxyglucose PET scanning
76. Nuclear medicine imaging in fever of unknown origin
77. Fever of unexplained origin: Report on 100 cases
78. Detection of infection in postoperative orthopedic patients with technetium-99m-labeled monoclonal antibodies against granulocytes
79. Iron salts and transferrin are specifically required for cell division of cultured 3T6 cells
80. Clinical utility of abdominal CT scanning in patients with HIV disease
81. Ringlike uptake of [18F] -FDG in brain abscess: A PET study
82. Indium-111 autologous leucocyte scanning in lobar pneumonia and lung abscesses
83. Indium-111 autologous leucocytes in inflammatory bowel disease
84. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques
85. Osteomyelitis: Diagnosis with in-111-labeled leucocytes
86. The scintigraphic diagnosis of osteomyelitis
87. Indium-111 Granulocyte Scintigraphy in the Evaluation of Patients with Fever of Undetermined Origin
88. Clinical PET imaging of inflammatory diseases
89. Granulocyte-specific monodonal antibody technetium-99m-BW 250/183 and indium-111 oxine-labeled leucocyte scintigraphy in inflammatory bowel disease
90. Glucose transporters and insulin action: Implications for insulin resistance and diabetes mellitus
91. Southwestern Internal Medicine Conference: Fever of undetermined origin: Not what it used to be
92. The (14C) deoxyglucose method for the measurement of local cerebral glucose utilisation: Theory, procedure and normal values in the conscious and anesthetized albino rat
93. Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma
94. The role of gallium-67 imaging in the detection of foci in recent cases of fever of unknown origin
95. Diagnostic significance of Indium-111 granulocyte scintigraphy in febrile patients
96. High [18F]-fluorodeoxyglacose uptake in abdominal abscesses: A PET study
97. Gallium scanning as a screening test for inflammatory lesions
98. The value of indium-111-labelled leucocyte imaging and ultrasonography in the investigation of pyrexia of unknown origin
99. Role of ironbinding proteins and enhanced capillary permeability on the accumulation of gallium-67
100. The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro
101. Imaging infection/inflammations
102. Glycogenolysis versus glucose transport in human granulocytes: Differential activation in phagocytosis and chemotaxis
103. Diagnostisches vorgehen bei fieber unbekannter ursache
104. Fieber, gewichtsverlust und seltene paraneoplasien
105. High accumulation of fluorine-18-fluorodeoxyclucose in turpentine-induced inflammatory tissue
106. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers